RE:We can expect a lot more...!So from what we know is that most biotech companies trade 10-15 times P/E. With a solid 1.5 mill from 3rd quarter we can speculate that the 4th quarter will be slighter higher than that from the available info from Tripp. I think we are still undervalued from that one quarter (the 3rd period lol) alone by a 2 million Mkt cap shortage. Now bring out the big guns and watch the 4th quarter(sunden death overtime) report shoot us upwards.. Things are on track, Milestone being reached and the valuations are correct. I'd like to see a P/E of 25 for the ground breaking work being release with the Aristotle concept . The market owes us that at least. Such a risky endeavour but with great risk comes great rewards.
RelevantStock wrote:
We have broken out of the 1.10 zone (and other levels after) with rapid buys of around 500-700k shares at most. I am expecting days with volume at least at 3-5M, maybe more, when we make the news for the launch of Aristotle, partnerships, revenue, etc. So happy of how we held this morning (and yesterday morning too). The new buyers here just arrived early for the front row tickets, much more to come.